Cme Group Inc. (CME) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Cme Group Inc. (CME) stock forecast summary
Our AI ranks Cme Group Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Cme Group Inc. is a large-cap company with a market capitalization of $99.97B. It ranks number 1 by market capitalization among the 9 Security & Commodity Brokers, Dealers, Exchanges & Services issuers in our coverage with a current forecast. Its Net Margin of 63.9% is the highest of the 8 peers that report one.
A per-ticker accuracy statistic for CME is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CME included.
Follow CME freeCME price chart and AI forecast
How CME ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cme Group Inc. (CME) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Security & Commodity Brokers, Dealers, Exchanges & Services peers listed below that report each metric.
Valuation & Market
| Metric | CME | Rank |
|---|---|---|
| Market Cap | $99.97B | 1/9 |
| P/E Ratio | 23.11x | 4/7 |
| P/B Ratio | 3.77x | 5/8 |
| Dividend Yield | 14.48% | 1/6 |
| EPS | $11.79 | – |
| Book Value/Share | $73.75 | – |
| Revenue/Share | $18.83 | – |
| FCF/Share | $11.72 | – |
Profitability & Margins
| Metric | CME | Rank |
|---|---|---|
| ROE | 16.3% | 6/8 |
| ROA | 2.2% | 6/8 |
| ROIC | 12.3% | 2/6 |
| Operating Margin | 65.1% | 1/7 |
| Net Margin | 63.9% | 1/8 |
| EBT Margin | 82.6% | 1/9 |
| Tax Rate | 23.4% | – |
Financial Health
| Metric | CME | Rank |
|---|---|---|
| Current Ratio | 1.02x | 4/6 |
| D/E Ratio | 6.34x | 2/9 |
| Financial Leverage | 7.34x | 2/9 |
| Interest Coverage | 15.8x | 3/6 |
| Working Capital | $2.91B | 1/6 |
Cash Flow
| Metric | CME | Rank |
|---|---|---|
| Operating Cash Flow | $4.31B | 2/9 |
| Free Cash Flow | $4.21B | 2/7 |
| Capital Spending | -$96M | 4/7 |
| OCF Growth YoY | 2.7% | 4/6 |
| FCF Growth YoY | 2.6% | 4/5 |
| FCF/Sales | 62.2% | 1/7 |
| CapEx/Sales | 1.4% | 5/7 |
Operational Efficiency
| Metric | CME | Rank |
|---|---|---|
| Asset Turnover | 0.03x | 7/7 |
| Receivables Turnover | 9.0x | – |
| Fixed Assets Turnover | 19.3x | 3/6 |
| Days Sales Outstanding | 41 days | – |
Income Statement
| Metric | CME | Rank |
|---|---|---|
| Total Revenue | $6.77B | 4/7 |
| Operating Income | $4.41B | 2/7 |
| Net Income | $4.33B | 1/8 |
Dividend & Shareholder Information
| Metric | CME | Rank |
|---|---|---|
| Dividends Per Share | $40.26 | – |
| Payout Ratio | 341.5% | 1/6 |
| Shares Outstanding | 360M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $161.63B | 83.0% of assets |
| Cash & Short-term Investments | $2.14B | 1.1% of assets |
| Accounts Receivable | $753M | 0.4% of assets |
| Total Liabilities | $168.16B | 86.4% of assets |
| Short-term Debt | $158.65B | 81.5% of assets |
CME quarterly financials and insider trading
Cme Group Inc. (CME) industry peers
Companies classified under the same SEC industry code as Cme Group Inc. (Security & Commodity Brokers, Dealers, Exchanges & Services): 11 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CME Cme Group Inc. | ▲ | $99.97B |
| ICE Intercontinental Exchange, Inc. | ▼ | $87.81B |
| NDAQ Nasdaq, Inc. | ▲ | $52.71B |
| CBOE Cboe Global Markets, Inc. | ▶ | $30.52B |
| LPLA Lpl Financial Holdings Inc. | ▶ | $25.64B |
| SNEX Stonex Group Inc. | ▲ | $7.28B |
| BGC Bgc Group, Inc. | ▲ | $5.54B |
| MRX Marex Group Ltd | ▲ | $5.25B |
| STEX Streamex Corp. | ▲ | $56M |
| SOS Sos Ltd | ▼ | N/A |
| WTF Waton Financial Ltd | ▼ | N/A |
Where CME sits on the market map
Cme Group Inc. (CME) stock news
Loading...
Cme Group Inc. (CME) stock forecast FAQ
What is the Cme Group Inc. (CME) stock forecast?
Our AI ranks Cme Group Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Cme Group Inc. stock predictions?
A per-ticker accuracy statistic for CME is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cme Group Inc. forecasts updated?
Cme Group Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Cme Group Inc.'s industry peers?
11 issuers in our coverage, CME included, share the SEC industry code Security & Commodity Brokers, Dealers, Exchanges & Services. The largest are: Intercontinental Exchange, Inc. (ICE), Nasdaq, Inc. (NDAQ), Cboe Global Markets, Inc. (CBOE), Lpl Financial Holdings Inc. (LPLA), Stonex Group Inc. (SNEX), Bgc Group, Inc. (BGC).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.